A.R.T. Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-6,183
| Closed | -$382K | – | 339 |
|
2019
Q4 | $382K | Sell |
6,183
-10,964
| -64% | -$677K | 0.02% | 948 |
|
2019
Q3 | $1.03M | Buy |
+17,147
| New | +$1.03M | 0.05% | 537 |
|
2018
Q2 | – | Sell |
-3,446
| Closed | -$278K | – | 1513 |
|
2018
Q1 | $278K | Buy |
+3,446
| New | +$278K | 0.01% | 1156 |
|
2017
Q2 | – | Sell |
-15,500
| Closed | -$477K | – | 1496 |
|
2017
Q1 | $477K | Buy |
15,500
+7,500
| +94% | +$231K | 0.02% | 822 |
|
2016
Q4 | $268K | Buy |
+8,000
| New | +$268K | 0.02% | 974 |
|
2016
Q2 | – | Sell |
-34,915
| Closed | -$1.03M | – | 1432 |
|
2016
Q1 | $1.03M | Buy |
34,915
+24,500
| +235% | +$719K | 0.05% | 577 |
|
2015
Q4 | $343K | Buy |
+10,415
| New | +$343K | 0.02% | 1002 |
|
2015
Q2 | – | Sell |
-89,103
| Closed | -$2.73M | – | 1535 |
|
2015
Q1 | $2.73M | Buy |
89,103
+70,756
| +386% | +$2.17M | 0.09% | 285 |
|
2014
Q4 | $932K | Buy |
+18,347
| New | +$932K | 0.03% | 670 |
|